Loading clinical trials...
Loading clinical trials...
A Phase II Study of RAD001 in Patients With Recurrent Endometrial Cancer
Conditions
Interventions
RAD001
Locations
1
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
June 1, 2004
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
May 1, 2025
NCT05489211
NCT04657068
NCT04585750
NCT07029399
NCT06975293
NCT07166094
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions